CHPA Seeks DSHEA Revamp, Monograph Transparency, Eased Rx-To-OTC Switches In Cures 2.0

By Jessica Karins / August 8, 2024 at 10:57 AM

The over-the-counter drug and supplement lobby calls for Congress to reform longstanding dietary supplement law to increase FDA oversight, insert more clarity in the OTC drug monograph process, allow non-animal testing methods and ease FDA’s Rx-to-OTC switch plan as part of a possible Cures 2.0 package next Congress.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.